INTENSITY THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
INTENSITY THERAPEUTICS, INC. (INTS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$174.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$47.00K, a 147.96% decline year-over-year.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$127.00K.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$331.00K.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $297.00K, a 386.89% increase year-over-year.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $13.00K.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$301.00K, a 114.56% decline from fiscal 2023.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $2.07M.
- INTENSITY THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$53.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$174.00K 10-Q · filed 2026-08-11 | -$505.00K derived: sum of 3 quarters · filed 2026-08-11 | -$208.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$127.00K 10-Q · filed 2026-05-07 | -$458.00K derived: sum of 2 quarters · filed 2026-05-07 | -$161.00K derived: sum of 3 quarters · filed 2026-05-07 | -$63.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$34.00K derived: sum of 2 quarters · filed 2026-03-27 | $64.00K derived: sum of 3 quarters · filed 2026-08-11 | $13.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $395.00K derived: sum of 2 quarters · filed 2026-08-11 | $344.00K 10-Q · filed 2025-11-06 | $139.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $47.00K 10-Q · filed 2026-08-11 | -$158.00K derived: sum of 3 quarters · filed 2026-08-11 | -$97.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$51.00K 10-Q · filed 2026-05-07 | -$256.00K derived: sum of 2 quarters · filed 2026-05-07 | -$195.00K derived: sum of 3 quarters · filed 2026-05-07 | $250.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$144.00K derived: sum of 2 quarters · filed 2026-03-27 | $301.00K derived: sum of 3 quarters · filed 2026-03-27 | -$301.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $506.00K derived: sum of 2 quarters · filed 2025-11-06 | -$96.00K 10-Q · filed 2025-11-06 | $1.26M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $445.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$157.00K 10-Q · filed 2025-08-07 | $1.20M derived: sum of 3 quarters · filed 2025-08-07 | $1.89M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$602.00K 10-Q · filed 2025-05-13 | $756.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.44M derived: sum of 3 quarters · filed 2025-05-13 | $1.48M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $2.05M derived: sum of 2 quarters · filed 2025-03-13 | $2.08M derived: sum of 3 quarters · filed 2025-03-13 | $2.07M 10-K · filed 2025-03-13 |
| 2023-09-30 | $688.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $719.00K derived: sum of 2 quarters · filed 2024-11-13 | $709.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $21.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$10.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$53.00K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |